Screen Reader Mode Icon

Question Title

* 1. Participant Name:

Question Title

* 2. Why did you join the MAT Learning Collaborative? Why was it important for you to attend these sessions?

Question Title

* 3. What is one key takeaway for you at the conclusion of the Learning Collaborative Sessions?

Question Title

* 4. How will you apply the lessons learned from this series of Learning Collaborative sessions to your work?

Question Title

* 5. Please respond to the following questions about each of the sessions using the dropdown menus. Under the dropdown menu, please select one of Strongly agree, Agree, Neither agree nor disagree, Disagree, or Strongly Disagree. If the question is not applicable to you, e.g. you did not attend the session, please select Not Applicable.

  The course content in this session is relevant to my work. The speakers were knowledgeable about the course content. The activities and discussion groups were effective in building key skills. This session provided clear next steps for me in my work. The pre-and post- tests were effective in assessing my change in knowledge.
Session 1 (Feb): Addiction 101, Common Myths & Pitfalls of MAT on Staten Island
Session 2 (March): Screenings, Assessment & Admissions Requirement
Session 3 (April): Buprenorphine Induction and Management
Session 4 (May): Co-Occurring Disorders and Special Populations
Session 5 (June): Value-Based Payment (Business Case for MAT)

Question Title

* 6. Please share any specific recommendations you may have for improving the sessions.

Question Title

* 7. Would you like to see additional Learning Collaborative sessions related to opioid use disorder based on the following topics?

  Yes No
Buprenorphine waiver training
Methadone and/or Vivitrol
MAT best practices in specific populations (pediatrics, pregnant women, veterans, geriatric, multi substance use)
Building linkages between primary care, EDs, and community-based providers

Question Title

* 8. If you would like to see other topics related to opioid use disorder that are not listed here, please specify:

Question Title

* 9. I would recommend this MAT Learning Collaborative series to other clinicians

Question Title

* 10. Please share your reason(s) for your response:

0 of 10 answered
 

T